Ghost Tree Capital, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.79 - $30.86 $3.56 Million - $6.17 Million
200,000 New
200,000 $3.7 Million
Q3 2018

Nov 14, 2018
BUY
$13.03 - $21.81 $6.52 Million - $10.9 Million
500,000 New
500,000 $7 Million
Q4 2017

Feb 14, 2018
SELL
$26.84 - $39.14 $2.93 Million - $4.27 Million
-109,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$29.49 - $38.37 $3.21 Million - $4.18 Million
109,000
109,000 $4.11 Million

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email